Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatrics

Understanding Biotinidase Deficiency: The Basics

At a Glance

Biotinidase deficiency is a rare but highly treatable genetic condition where the body cannot properly recycle the vitamin biotin. Caught early through newborn screening, it is effectively managed with a daily oral biotin supplement, allowing babies to grow up with normal, healthy development.

Getting a phone call from your pediatrician about a “positive” newborn screening result is a moment of pure, understandable panic for any parent. However, it is important to take a deep breath: biotinidase deficiency is often called a “success story” of modern medicine because the solution is as simple as the diagnosis is scary [1][2].

Stabilizing Facts for the First 24 Hours

When you first hear the news, your mind may jump to the worst-case scenario. Here are three facts to help you ground yourself:

  1. It is highly treatable: This is not a condition that requires surgery or complex hospital stays. Treatment is a daily dose of a vitamin called biotin [3][4].
  2. The prognosis is excellent: Children caught through newborn screening who begin treatment immediately typically grow up with normal health and development [2][5].
  3. Treatment is simple: Your baby will likely just need a small amount of biotin (a B-vitamin) every day for the rest of their life to keep them healthy [4][6].

What is Biotinidase Deficiency?

To understand this condition, think of the body as a recycling center. Your body uses a vitamin called biotin to help process fats, proteins, and carbohydrates [7]. Normally, an enzyme called biotinidase “recycles” the biotin your body already has so it can be used over and over again [7][8].

In babies with this deficiency, the recycling enzyme doesn’t work correctly. Without that recycling process, the body runs out of biotin, which can lead to a buildup of harmful acids in the blood and urine and a severe shortage of energy for the body’s cells [3][8].

Why the Screening Caught It

Newborn screening is designed to find this condition before any symptoms appear. The “heel stick” test your baby had at the hospital measured the activity level of the biotinidase enzyme [1].

  • Profound Deficiency: The enzyme activity is less than 10% of normal. These babies need treatment immediately to prevent symptoms [9][10].
  • Partial Deficiency: The enzyme activity is between 10% and 30% of normal. These babies may only show symptoms during times of extreme stress or illness, but doctors usually recommend treatment as a safeguard [9][10].

Incidence and Genetics

Biotinidase deficiency is rare, affecting approximately 1 in 60,000 babies worldwide [3]. It is an autosomal recessive genetic condition, meaning a baby must inherit one non-working gene from each parent to have the deficiency [3]. Most parents are “carriers” and have no idea they carry the gene until their baby is screened.

Important Safety Note: Lab Tests and Supplements

While biotin is a safe vitamin, the high doses used to treat this condition can interfere with common laboratory tests (like thyroid tests) by tricking the lab equipment [11]. It is vital to tell every doctor your child sees that they are taking high-dose biotin so the lab can adjust their testing methods.

Additionally, when purchasing biotin, it is safest to use a pure, single-ingredient biotin supplement rather than complex “Hair, Skin, and Nails” blends, which contain unnecessary and potentially harmful extra vitamins for infants [12][13].

Common questions in this guide

What does a positive newborn screening for biotinidase deficiency mean?
A positive newborn screening means your baby's body may have trouble recycling biotin, a necessary vitamin for processing fats, proteins, and carbohydrates. The screening measures the activity level of the biotinidase enzyme to determine the severity of the deficiency.
How is biotinidase deficiency treated?
Treatment is very straightforward and consists of giving your baby a daily oral dose of the vitamin biotin. When caught early and treated consistently, children with this condition typically enjoy completely normal health and development.
What is the difference between profound and partial biotinidase deficiency?
Profound deficiency means the enzyme is operating at less than 10% of its normal capacity and requires immediate daily treatment. Partial deficiency means the enzyme has 10% to 30% activity, which may only cause symptoms during times of extreme stress or illness.
Will biotin treatment interfere with my baby's future lab tests?
Yes, the high doses of biotin used to treat this condition can trick laboratory equipment and alter the results of common blood tests, such as thyroid panels. You must always inform every doctor and lab technician that your child takes high-dose biotin before any bloodwork is drawn.
Can I use over-the-counter hair and skin vitamins for my baby's biotin?
No, it is safest to use a pure, single-ingredient biotin supplement recommended by your doctor. Over-the-counter blends formulated for hair, skin, and nails contain extra vitamins and ingredients that are unnecessary and potentially harmful to infants.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the exact enzyme activity level from the screening (profound vs. partial)?
  2. 2.Can you help me understand our child's specific genetic variants (the BTD gene analysis)?
  3. 3.What is the exact daily dose of biotin we need to give, and how should we administer it to an infant?
  4. 4.How will the biotin supplement interfere with future blood tests, and which tests should we warn other doctors about?
  5. 5.Since biotin is a common vitamin, can we just use over-the-counter supplements, or do we need a specific medical-grade version?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Neonatal screening for biotinidase deficiency: A 30-year single center experience.

    Porta F, Pagliardini V, Celestino I, et al.

    Molecular genetics and metabolism reports 2017; (13()):80-82 doi:10.1016/j.ymgmr.2017.08.005.

    PMID: 28971021
  2. 2

    Frequency of biotinidase gene variants and incidence of biotinidase deficiency in the Newborn Screening Program in Minas Gerais, Brazil.

    Carvalho NO, Januário JN, Felix GLP, et al.

    Journal of medical screening 2020; (27(3)):115-120 doi:10.1177/0969141319892298.

    PMID: 31801038
  3. 3

    Two novel BTD mutations causing profound biotinidase deficiency in a Chinese patient.

    Geng J, Sun Y, Zhao Y, et al.

    Molecular genetics & genomic medicine 2021; (9(2)):e1591 doi:10.1002/mgg3.1591.

    PMID: 33452876
  4. 4

    Biotinidase Deficiency Induced Optic Neuropathy: A Case Report and Literature Review.

    Cao AA, Brown MM, Lee MS, et al.

    Neuro-ophthalmology (Aeolus Press) 2025; (49(3)):224-231 doi:10.1080/01658107.2024.2424209.

    PMID: 40190376
  5. 5

    Successful outcomes of older adolescents and adults with profound biotinidase deficiency identified by newborn screening.

    Wolf B

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(4)):396-402 doi:10.1038/gim.2016.135.

    PMID: 27657684
  6. 6

    Biotinidase Deficiency: Prevalence, Impact And Management Strategies.

    Canda E, Kalkan Uçar S, Çoker M

    Pediatric health, medicine and therapeutics 2020; (11()):127-133 doi:10.2147/PHMT.S198656.

    PMID: 32440248
  7. 7

    Molecular Mechanisms of Biotin in Modulating Inflammatory Diseases.

    Sakurai-Yageta M, Suzuki Y

    Nutrients 2024; (16(15)) doi:10.3390/nu16152444.

    PMID: 39125325
  8. 8

    Mutations in BTD gene causing biotinidase deficiency: a regional report.

    Kasapkara ÇS, Akar M, Özbek MN, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(3-4)):421-4.

    PMID: 25423671
  9. 9

    Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening.

    Cicalini I, Pieragostino D, Rizzo C, et al.

    International journal of environmental research and public health 2021; (18(4)) doi:10.3390/ijerph18041659.

    PMID: 33572391
  10. 10

    Evaluation of 700 patients referred with a preliminary diagnosis of biotinidase deficiency by the national newborn metabolic screening program: a single-center experience.

    Erdol S, Kocak TA, Bilgin H

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(6)):555-560 doi:10.1515/jpem-2023-0003.

    PMID: 37119528
  11. 11

    Serum Level of Biotin Rather than the Daily Dosage Is the Main Determinant of Interference on Thyroid Function Assays.

    Paketçi A, Köse E, Gürsoy Çalan Ö, et al.

    Hormone research in paediatrics 2019; (92(2)):92-98 doi:10.1159/000502740.

    PMID: 31655813
  12. 12

    Biotinidase deficiency: A treatable cause of hereditary spastic paraparesis.

    Radelfahr F, Riedhammer KM, Keidel LF, et al.

    Neurology. Genetics 2020; (6(6)):e525 doi:10.1212/NXG.0000000000000525.

    PMID: 33134520
  13. 13

    A retrospective study on biotinidase deficiency: analysis of the Eastern Anatolia region patient cohort.

    Yaralı O, Arslan S, Gündoğdu Öğütlü ÖB, et al.

    Scandinavian journal of clinical and laboratory investigation 2024; (84(7-8)):470-476 doi:10.1080/00365513.2024.2420320.

    PMID: 39451125

This information is for educational purposes to help parents understand biotinidase deficiency screening results. Always consult your pediatrician or metabolic geneticist for specific diagnosis, genetic testing analysis, and exact biotin dosing.

Get notified when new evidence is published on Biotinidase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.